Chris Belmont, vice president and chief information officer, MD Anderson Cancer Center, says that health systems like Ochsner are using data to validate what they already know about certain patient cases.
Chris Belmont, vice president and chief information officer, MD Anderson Cancer Center, says that health systems like Ochsner are using data to validate what they already know about certain patient cases.
“For example, we’re monitoring patients in their home, so we’re providing them with devices so that we can stay connected with them after they leave. We know things that occur in the first 7 days, or actually first 14 days, are one of the big the reasons for readmissions,” says Mr Belmont. “The typical approach was to have someone—say from Home Health or someone call them and monitor them—but now we have devices that are collecting data more frequently.”
Mr Belmont suggests that instead of having someone manually go out to take patient information every few days, health systems can electronically “visit” patients as often as desired. For those patients managing chronic conditions such as high blood pressure, or health issues like obesity, electronic health monitoring can be more convenient.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen